AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 291: F1281-F1287, 2006. First published July 25, 2006; doi:10.1152/ajprenal.00221.2006
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/F1281    most recent
00221.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franco, M.
Right arrow Articles by Herrera-Acosta, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franco, M.
Right arrow Articles by Herrera-Acosta, J.

Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension

Martha Franco,1 Flavio Martínez,4 Bernardo Rodríguez-Iturbe,2 Richard J. Johnson,3 José Santamaría,1 Angélica Montoya,4 Tomas Nepomuceno,1 Rocío Bautista,1 Edilia Tapia,1 and Jaime Herrera-Acosta1,{dagger}

1Department of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City; 2Hospital Universitario, Instituto de Investigaciones Biomédicas, Universidad del Zulia, Maracaibo, Venezuela; 3Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida; and 4Department of Pharmacology, Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico

Submitted 16 June 2006 ; accepted in final form 21 July 2006

Transient administration of ANG II causes persistent salt-sensitive hypertension associated with arteriolopathy, interstitial inflammation, and cortical vasoconstriction; blocking the vascular and inflammatory changes with mycophenolate mofetil (MMF) prevents vasoconstriction. While infiltrating leukocytes during the salt-sensitive hypertension phase express ANG II, the functional role of ANG II during this phase is not known. We examined the acute effect of candesartan on renal hemodynamics during the established salt-sensitive hypertensive phase and related these findings to direct measurement of intrarenal ANG II and inflammatory cells in rats previously exposed to ANG II with or without MMF treatment. Sham controls were also examined. The administration of ANG II, followed by exposure to high-salt diet, resulted in hypertension, cortical vasoconstriction, an increase in interstitial inflammatory cells (44.8 ± 1.3 lymphocytes/mm2, and 30.8 ± 1.2 macrophages/mm2 ANG II vs. 19.6 ± 2 lymphocytes/mm2, and 22 ± 0.7 macrophages/mm2 Sham), and increase in renal ANG II levels (1,358 ± 74.6 pg/ml ANG II vs. 194 ± 9.28 pg/ml Sham). Treatment with MMF during the administration of exogenous ANG II resulted in reduction in renal interstitial inflammation (19.7 ± 0.9 lymphocytes/mm2 and 15.9 ± 0.8 machophages/mm2), ANG II levels (436.9 ± 52.29 pg/ml), cortical vasoconstriction, and stable blood pressure levels during the subsequent challenge with a high-salt diet. Acute administration of candesartan similarly reduced renal vasoconstriction and blood pressure. We conclude that the cortical vasoconstriction occurring with salt-sensitive hypertension following exposure to ANG II is mediated by intrarenal ANG II, related, at least in part, to the interstitial inflammation.

renal hemodynamics; candesartan; AT1 angiotensin II receptor blockade



Address for reprint requests and other correspondence: M. Franco, Nephrology Dept., Instituto Nacional de Cardiología I Ch, Juan Badiano No. 1, Mexico City, Tlalpan 14080, Mexico (e-mail: marthafranco{at}lycos.com)




This article has been cited by other articles:


Home page
HypertensionHome page
B. Rodriguez-Iturbe, N. D. Vaziri, and R. J. Johnson
Inflammation, Angiotensin II, and Hypertension
Hypertension, November 1, 2008; 52(5): e135 - e135.
[Full Text] [PDF]


Home page
HypertensionHome page
S. F. Knight, J. E. Quigley, J. Yuan, S. S. Roy, A. Elmarakby, and J. D. Imig
Endothelial Dysfunction and the Development of Renal Injury in Spontaneously Hypertensive Rats Fed a High-Fat Diet
Hypertension, February 1, 2008; 51(2): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Bravo, Y. Quiroz, A. Ferrebuz, N. D. Vaziri, and B. Rodriguez-Iturbe
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F616 - F623.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Franco, F. Martinez, Y. Quiroz, O. Galicia, R. Bautista, R. J. Johnson, and B. Rodriguez-Iturbe
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R251 - R256.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Rodriguez-Iturbe and N. D. Vaziri
Salt-sensitive hypertension--update on novel findings
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 992 - 995.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.